Show results for
Refine by
Dna Rna Target Equipment & Supplies In Iraq
34 equipment items found
Manufactured by:Fusion Genomics Corporation based inBurnaby, BRITISH COLUMBIA (CANADA)
QUANTUMProbes, the second component of our ONETest molecular diagnostics assay kit, are comprised of synthetic non-reference based oligonucleotides designed using Fusion Genomics’ machine learning algorithms. ...
Manufactured by:Massive Photonics GmbH based inMünchen, GERMANY
The MASSIVE-sdAB 1-PLEX Kit from Massive Photonics is designed for DNA-PAINT imaging applications, providing a camelid single-domain antibody (sdAB) to target mouse IgG kappa light chain or rabbit IgG. Engineered for precision, the sdAB is site-specifically coupled to a DNA-PAINT docking site, allowing for improved binding efficiency. This kit enhances imaging accuracy by reducing linkage errors ...
Manufactured by:Massive Photonics GmbH based inMünchen, GERMANY
The Primary Antibody Labeling Kit from Massive Photonics is designed for advanced FAST DNA-PAINT imaging, specifically targeting mouse IgG kappa light chain or rabbit IgG primary antibodies. This kit leverages camelid single-domain antibodies (sdABs) coupled to DNA-PAINT sites optimized for rapid imaging and high signal-to-noise ratios. The incorporation of FAST sequences significantly reduces ...
Manufactured by:INOVIO Pharmaceuticals based inPlymouth Meeting, PENNSYLVANIA (USA)
INOVIO’s DNA medicines are made using a process called SynCon®. SynCon uses a proprietary computer algorithm that has been designed to identify and optimize the DNA sequence of the target antigen, whether it is a virus or a tumor. Once this sequence has been determined, the DNA is synthesized or reorganized, and manufacturing can ...
Manufactured by:Panagene Inc. based inDaejeon, SOUTH KOREA
HPV is well-known as as major cause of cervical cancer. More than 40 pathogens in 100 kinds of HPV has been found in female genital organ. The High-Risk group of those viruses is generally known for a direct correlation with cervical cancer. That is why WHO highly recommend the HPV DNA test. PANA RealTyper™ HPV Kit can detect 14 pathogens of High risk group and 2 pathogens of Low risk ...
Manufactured by:Panagene Inc. based inDaejeon, SOUTH KOREA
Mutations of IDH1 (isocitrate dehydrogenase 1,IDH1) can be found in glioblastoma and myeloproliferative neoplasm. Detection of IDH1mutations can be a positive predictor of a prognosis and a molecular marker for glioblastoma patients. On the other hand, it is reported that IDH1 mutations correlate with poor prognosis in myeloproliferative neoplasm. PNAClamp™ IDH1 Mutation Detection Kit is a ...
Manufactured by:LGC SeraCare based inMilford, MASSACHUSETTS (USA)
The Seraseq Tumor Mutation DNA Mix v2 (AF7) HC is a multiplexed mixture of actionable biosynthetic DNA targets precisely blended with a single, well-characterized genomic background. This product is produced under rigorous design control and manufacturing practices to an allelic frequency of 7%, and is offered in a high concentration (HC) format at 25 ng/µL. Designed to assess the overall ...
Manufactured by:Solis BioDyne based inTartu, ESTONIA
Dye-based real-time quantitative PCR (qPCR) uses DNA binding dye to evaluate the DNA amplification process during PCR. In this mix EvaGreen® double-stranded DNA binding dye is used instead of the more widely used SYBR Green I that has similar fluorescence spectra. Compared to SYBR Green I dye EvaGreen® dye shows a higher fluorescence level, high sensitivity for detecting low template ...
Manufactured by:Panagene Inc. based inDaejeon, SOUTH KOREA
BRAF mutation is found in several cancers including thyroid cancer, malignant melanoma, ovarian cancer, colorectal cancer. In case of thyroid cancer, there are over 40 different types of BRAF mutation. Of these mutations, the V600E mutation on exon 15, i.e. change of nucleotide from T to A in 1799th base that results in change from valine to glutamate in amino acids, is most important with over ...
Manufactured by:Panagene Inc. based inDaejeon, SOUTH KOREA
NRAS mutation is found in several cancers such as melanoma (13~25%), colorectal cancer (1~6%), lung cancer (1%), thyroid cancer (7%) and hepatocellular carcinoma (10%). It is know that the drug response against colorectal cancer medicine such as Erbitux and Cetuximab decreased and the prognosis of the metastatic colorectal cancer patient is bad if the patient has NRAS mutation. Recently, there ...
Manufactured by:BioChek BV based inReeuwijk, NETHERLANDS
A highly sensitive and specific PCR test kit allowing simultaneous differentiation and quantification of Campylobacter Coli, Campylobacter Jejuni and/or Campylobacter Lari DNA, extracted from primary production, production environment, and food samples, including sample ...
Manufactured by:Amoy Diagnostics Co., Ltd. based inXiamen, CHINA
The phosphoinositide-3 -kinase catalytic alpha (PIK3CA) gene produces the p110 alpha (pl 10a) protein, which is one subunit of an enzyme called phosphatidylinositol 3-kinase (PI3K). PI3K plays a key role ofPI3K/Akt signaling pathway in numerous cellular processes critical for cancer progression, including metabolism, growth, survival, and motility. Somatic mutations in the PIK3CA gene are found ...
Manufactured by:Panagene Inc. based inDaejeon, SOUTH KOREA
According to the WHO report (2008), human papillomavirus (HPV) causes virtually 100% of cases of cervical cancers. There are more than 100 genotypes of HPV reported currently, and HPV consists of double helix circular DNA with ca. 7,900 bps. Compared to the traditional Pap smear test, HPV genotyping has several advantages; 1) high accuracy of determining existence of HPV viruses, 2) genotyping of ...
Manufactured by:Fluxergy based inIrvine, CALIFORNIA (USA)
Simple Molecular Testing and More at Your Practice. Fluxergy provides a solution that eliminates the Friday dilemma of waiting for lab results on the weekend. Design and build PCR tests at your practice that give you results within 1 ...
by:Thermo Fisher Scientific, LIMS & Laboratory Software based inPhiladelphia, PENNSYLVANIA (USA)
qPCR system for quantitation of residual plasmid DNA. Multiplex assay that targets all kanamycin resistance (KanR) gene alleles common in bioproduction. Highly specifi c quantitation through innovative DNA-free master mix. Highly sensitive quantitation using proven Applied Biosystems TaqMan real-time PCR technology. Reproducible results with manual and automated sample preparation, optimized for ...
Manufactured by:Celemics, Inc. based inSeoul, SOUTH KOREA
“Unlike Whole Genome Sequencing, Targeted Sequencing is a technique that selectively analyzes specific regional sequences of genomes.” Our Target Enrichment Panel uses hybridization-based capture technology to enable the core process of Target Sequencing, which is the separation and analysis of specific regional sequences of entire genomes. It can also accurately analyze all types of ...
Manufactured by:EntroGen, Inc. based inWoodland Hills, CALIFORNIA (USA)
EntroGen NGS Targeted Hotspot Panel is a comprehensive pan-cancer assay designed to detect clinically relevant hotspot mutations in solid tumors. Utilizing a robust next-generation sequencing (NGS) platform, labs are able to simultaneously analyze several different tumor types by batching up to 12 samples on a single run*. NGS Targeted Hotspot Panel (THSP) is compatible with fresh frozen, and ...
Manufactured by:Panagene Inc. based inDaejeon, SOUTH KOREA
KRAS mutation is found in several cancers such as pancreatic cancer, colorectal cancer, lung cancer, biliary tract cancer and thyroid cancer. The existence of KRAS mutations is often related with a prognostic marker to drug response. For example, KRAS mutation is considered a strong prognostic marker for drug response of tyrosine kinase inhibitors such as Gefitinib (Iressa) or Erlotinib ...
Manufactured by:Amoy Diagnostics Co., Ltd. based inXiamen, CHINA
The Homologous Recombination Repair (HRR) pathway plays an important role in double strand break, which is the major cause of cancer development. It has been demonstrated that loss of function of HRR genes (e.g. BRCA1, BRCA2, PALB2) and homologous recombination deficiency (HRD) will cause a higher risk of developing cancer, and patients with HRR gene mutations showed higher response to PARPi and ...
Manufactured by:Fluxergy based inIrvine, CALIFORNIA (USA)
Learn more about Fluxergy’s qualitative real-time reverse transcription polymerase chain reaction (RT-qPCR) test. For Research Use Only (RUO). Not for use in diagnostic ...